Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ADH1C | P00326 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27792048 | 1.00 | ALDH1A1 (0.35) | ALDH1A1ADH1AMEN1KMT2AADH1C | |
| SCHEMBL25804279 | 0.83 | ALDH1A1 (0.38) | ALDH1A1ADH1AMEN1KMT2AADH1C | |
| SCHEMBL3589654 | 0.83 | ADH1A (0.36) | ALDH1A1ADH1AMEN1KMT2AADH1C | |
| SCHEMBL14413802 | 0.83 | MEN1 (0.47) | ALDH1A1ADH1AMEN1KMT2AADH1C | |
| SCHEMBL7760713 | 0.81 | ALDH1A1 (0.37) | ALDH1A1ADH1AMEN1KMT2AADH1C | |
| SCHEMBL25211965 | 0.80 | ADH1A (0.47) | ALDH1A1ADH1AMEN1KMT2AADH1C | |
| SCHEMBL11505771 | 0.79 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1 | |
| SCHEMBL9420629 | 0.78 | ADH1A (0.41) | ALDH1A1ADH1AMEN1KMT2AADH1C | |
| SCHEMBL1416138 | 0.76 | ALOX5 (0.42) | ALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL647829 | 0.75 | TRPM8 (0.45) | ALDH1A1ADH1AMEN1KMT2AADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2121642-A1 | 4-HYDR0XY-2-0X0-2, 3 -DIHYDRO- 1, 3-BENZOTHIAZOL- 7YL COMPOUNDS FOR MODULATION OF B2-ADRENORECEPTOR ACTIVITY | AstraZeneca AB (SE) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008075026-A1 | 4-HYDR0XY-2-0X0-2, 3 -DIHYDRO- 1, 3-BENZOTHIAZOL- 7YL COMPOUNDS FOR MODULATION OF B2-ADRENORECEPTOR ACTIVITY | ASTRAZENECA AB (SE) | 2008-06-26 | — | — | WO | disclosed |